"The U.S. Food and Drug Administration today expanded the approved use of the CoreValve System to treat certain patients who have previously had a tissue aortic valve replacement and are in need of a second one.
This first-of-its-kind use is"...
Bretylium (bretylium tosylate injection ) tosylate injection is an antifibrillatory and antiarrhythmic agent; intended for intravenous or intramuscular use. It has a molecular formular: C18H24BrNO3S.
Bretylium (bretylium tosylate injection ) tosylate is a white, crystalline powder with an extremely bitter taste. It is freely soluble in water and alcohol. Each mL of sterile, nonpyrogenic solution contains 50mg bretylium (bretylium tosylate injection ) tosylate in Water for Injection, USP. The pH is adjusted, when necessary, with dilute hydrochloric acid and/or sodium hydroxide. Bretylium (bretylium tosylate injection ) tosylate injection contains no preservative.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Bretylium Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.